Objectives To assess the tolerance and potential nutritional consequences of long-term
repeated doses of PEG 4000 (10 to 30 g/day) in elderly patients with chronic constipation as …

Aim: To compare standard and maximum daily doses of polyethylene glycol 3350 plus
electrolytes (Transipeg) and polyethylene glycol 4000 (Forlax) in a multicentre, double …

Background Polyethylene glycol (PEG) is a commonly used osmotic laxative. PEG with
electrolytes is mixed with water, but PEG without electrolytes can also be mixed with, for …

Abstract Background Polyethylene glycol 3350 (MiraLAX, Braintree Laboratories Inc.,
Braintree, MA, USA) is approved for the short‐term treatment of occasional constipation. Aim …

Objective: To explore the clinical dimensions of chronic constipation and the role played in
its treatment by laxatives in general and by polyethylene glycol 3350 (MiraLAX) in particular …

Purpose To evaluate the safety and tolerability of aqueous solution concentrate (ASC) of
polyethylene glycol (PEG) 3350 in patients with functional constipation. Patients and …

OBJECTIVES Polyethylene glycol (PEG) 3350 (MiraLAX) is currently approved for the short-
term treatment of occasional constipation. This study was designed to compare the safety …

Background & Aims. The efficacy and safety of polyethylene glycol 3350 for chronic
idiopathic constipation have been demonstrated in randomized controlled trials. A new US …

Background: Although lactulose and polyethylene glycol are osmotic laxatives widely used
in the treatment of chronic constipation, no study has been conducted to compare their …

Slow transit constipation is notoriously difficult to treat. We tested whether polyethylene
glycole 4000 (PEG) improves slow transit constipation. Eight female outpatients with …